Published in BMC Cancer on June 14, 2013
Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells. Mol Cancer (2015) 1.03
Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm. BMC Med (2013) 0.95
Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients. J Cancer Res Clin Oncol (2014) 0.94
The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells. Oncotarget (2015) 0.81
Identifying and targeting tumor-initiating cells in the treatment of breast cancer. Endocr Relat Cancer (2015) 0.81
ERrrr…Where are the Progenitors? Hormone Receptors and Mammary Cell Heterogeneity. J Mammary Gland Biol Neoplasia (2015) 0.79
Toward precision medicine of breast cancer. Theor Biol Med Model (2016) 0.77
Characterization of the CD49f+/CD44+/CD24- single-cell derived stem cell population in basal-like DCIS cells. Oncotarget (2016) 0.77
Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors. Oncogene (2015) 0.77
P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice. Mod Pathol (2017) 0.75
Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors. PLoS One (2014) 0.75
Isolated Rat Epididymal Basal Cells Share Common Properties with Adult Stem Cells. Biol Reprod (2015) 0.75
Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget (2016) 0.75
Obesity and p16(INK4A) Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol (2017) 0.75
Nanotechniques Inactivate Cancer Stem Cells. Nanoscale Res Lett (2017) 0.75
PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation. Int J Cancer (2017) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer (2008) 18.08
Molecular definition of breast tumor heterogeneity. Cancer Cell (2007) 12.67
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst (2008) 11.93
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med (2009) 10.88
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res (2008) 7.65
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell (2010) 4.66
Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell (2007) 4.30
Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res (1997) 4.22
Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res (2005) 3.74
A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med (2008) 3.64
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia (2006) 3.54
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res (2005) 3.52
CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene (2011) 3.08
Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland. Breast Cancer Res (2012) 2.18
Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer (2008) 2.11
Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res (1982) 2.07
Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci U S A (2011) 2.01
Detection and analysis of mammary gland stem cells. J Pathol (2009) 1.96
Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia (2005) 1.74
The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas. Hum Pathol (2008) 1.59
Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? Breast Cancer Res (2007) 1.57
Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells. Int J Cancer (2007) 1.53
The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells (2010) 1.34
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance. Breast Cancer Res (2011) 1.29
Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology (1999) 1.25
Separating stem cells by flow cytometry: reducing variability for solid tissues. Cell Stem Cell (2009) 1.20
Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol (2004) 1.16
A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer. Breast Cancer Res Treat (2011) 1.15
Establishment and characterization of a new cell line derived from a human primary breast carcinoma. Cancer Genet Cytogenet (2000) 0.95
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia (2006) 3.54
Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes (2008) 2.25
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol (2009) 2.15
Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood (2006) 1.70
FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy. BMC Cancer (2008) 1.63
Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells. Int J Cancer (2007) 1.53
Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res (2008) 1.45
A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J Exp Med (2004) 1.25
Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Clin Cancer Res (2005) 1.20
Human HTm4 is a hematopoietic cell cycle regulator. J Clin Invest (2002) 1.15
Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet (2005) 1.14
Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS One (2011) 1.10
Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer (2007) 1.08
Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS One (2013) 1.07
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule. Breast Cancer Res (2010) 1.03
Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol (2002) 1.03
TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD. Cell Signal (2006) 1.01
Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene (2005) 0.99
RGA protein associates with a TRPV ion channel during biosynthesis and trafficking. J Cell Biochem (2004) 0.96
The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene (2004) 0.95
Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. Int J Gynecol Cancer (2011) 0.95
Transplant tourism outcome: a single center experience. Transplantation (2010) 0.94
Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia. Gynecol Oncol (2011) 0.94
Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma. Int J Oncol (2011) 0.94
Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients. Exp Hematol (2009) 0.93
Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy. Am J Surg (2002) 0.92
Genetic diagnosis in consanguineous families with kidney disease by homozygosity mapping coupled with whole-exome sequencing. Am J Kidney Dis (2011) 0.91
Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues. J Cell Mol Med (2011) 0.90
Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2. J Biol Chem (2005) 0.89
Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy. PLoS One (2011) 0.89
Identification of granulocyte subtype-selective receptors and ion channels by using a high-density oligonucleotide probe array. J Allergy Clin Immunol (2004) 0.89
PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells. Breast Cancer Res Treat (2010) 0.88
p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition. Neoplasia (2012) 0.88
Cytomorphologic differentiation of Hodgkin's lymphoma and Ki-1+ anaplastic large cell lymphoma in fine needle aspirates. Acta Cytol (2003) 0.87
Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer. Breast Cancer Res Treat (2015) 0.87
Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic. J Pathol (2013) 0.86
Grading of follicular lymphoma using flow cytometry. Ann Saudi Med (2006) 0.86
Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis. Cancer Genomics Proteomics (2010) 0.84
Vincristine and lomustine induce apoptosis and p21(WAF1) up-regulation in medulloblastoma and normal human epithelial and fibroblast cells. J Neurooncol (2007) 0.83
Differential marker expression by cultures rich in mesenchymal stem cells. BMC Cell Biol (2013) 0.83
The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females. BMC Cancer (2014) 0.83
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. Biochem J (2005) 0.82
Cell cycle disruption and apoptotic activity of 3-aminothiazolo[3,2-a]benzimidazole-2-carbonitrile and its homologues. Eur J Med Chem (2010) 0.81
Ovarian angiosarcoma: a case report and review of the literature. J Med Case Rep (2014) 0.80
18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg (2003) 0.80
Cellular schwannoma of the paranasal sinuses: initial report of a case. Ear Nose Throat J (2002) 0.80
Proteomic analysis of soft tissue tumor implants treated with a novel polybisphosphonate. Cancer Genomics Proteomics (2014) 0.80
The nexus between VEGF and NFκB orchestrates a hypoxia-independent neovasculogenesis. PLoS One (2013) 0.79
Clinicopathologic features of hepatic neoplasms in explanted livers: a single institution experience. Ann Saudi Med (2007) 0.78
TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution. Oncol Lett (2011) 0.76
The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women. Oncol Lett (2012) 0.76
Breast cancer: is there a viral connection? Adv Anat Pathol (2014) 0.75
18-fluorodeoxyglucose positron emission tomography in cystic carcinoma of the breast. Breast J (2002) 0.75